Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a Danish nationwide real-world study.
Mouritzen MT, Junker KF, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Homann PH, Kristensen EB, Drivsholm LB, Bøgsted M, Christensen HS, Pøhl M, Bjørnhart B. Mouritzen MT, et al. Among authors: livbjerg a. Acta Oncol. 2022 Apr;61(4):409-416. doi: 10.1080/0284186X.2021.2023213. Epub 2022 Jan 11. Acta Oncol. 2022. PMID: 35012430 Free article.
Nationwide Survival Benefit after Implementation of First-Line Immunotherapy for Patients with Advanced NSCLC-Real World Efficacy.
Mouritzen MT, Carus A, Ladekarl M, Meldgaard P, Nielsen AWM, Livbjerg A, Larsen JW, Skuladottir H, Kristiansen C, Wedervang K, Schytte T, Hansen KH, Østby AC, Frank MS, Lauritsen J, Sørensen JB, Langer SW, Persson GF, Andersen JL, Frary JMC, Drivsholm LB, Vesteghem C, Christensen HS, Bjørnhart B, Pøhl M. Mouritzen MT, et al. Among authors: livbjerg a. Cancers (Basel). 2021 Sep 28;13(19):4846. doi: 10.3390/cancers13194846. Cancers (Basel). 2021. PMID: 34638329 Free PMC article.
DaBlaCa-16: Retrosigmoid Versus Conventional Ileal Conduit in Robot-assisted Radical Cystectomy, the MOSAIC Randomized Controlled Trial-Feasibility and 90-day Postoperative Complications.
Brandt SB, Körner SK, Milling RV, Nielsen NK, Kingo PS, Joensen UN, Bro L, Jensen TK, Livbjerg AH, Fabrin K, Vrang ML, Vangedal M, Lam GW, Jensen JB. Brandt SB, et al. Among authors: livbjerg ah. Eur Urol Open Sci. 2024 Jan 4;60:8-14. doi: 10.1016/j.euros.2023.12.007. eCollection 2024 Feb. Eur Urol Open Sci. 2024. PMID: 38375343 Free PMC article.